The Protein Buildup Behind Lewy Body Dementia

Lewy body dementia develops when a protein called alpha-synuclein accumulates inside nerve cells in the brain. These clumps, called Lewy bodies, damage and kill neurons, disrupting the brain's ability to process information, regulate movement, and manage sleep and mood. The disease is the second most common type of dementia after Alzheimer's, but the mechanism is fundamentally different—it is not primarily about amyloid plaques or tau tangles, but rather these abnormal protein deposits spreading through specific brain regions.

Scientists do not yet fully understand why alpha-synuclein misfolds and accumulates in some people and not others. The protein normally exists in healthy brains, but in Lewy body dementia it adopts an abnormal shape, clumps together, and resists the brain's natural cleanup processes. This buildup typically begins in the brainstem (the lower part of the brain controlling basic functions like breathing and sleep) and spreads upward into regions that govern memory, attention, and movement.

Key Takeaways

  • Lewy body dementia is caused by abnormal accumulation of alpha-synuclein protein in brain cells, which damages and kills neurons over time.
  • The protein clumps typically start in the brainstem and spread to the cortex, affecting sleep, movement, mood, and thinking in ways that differ from Alzheimer's disease.
  • Age is the strongest known risk factor, with most cases appearing after age 50, but genetics, environmental exposures, and head injury may also play a role.
  • Lewy bodies often coexist with Alzheimer's pathology or Parkinson's disease changes, making diagnosis complex and symptoms variable between individuals.

Why Age Is the Primary Risk Factor

The single strongest predictor of Lewy body dementia is age. The disease is rare before age 50 and becomes increasingly common in the 70s and 80s. This pattern suggests that alpha-synuclein accumulation is a slow process that requires years or decades to reach levels that cause noticeable cognitive decline. It also hints that aging itself—changes in how cells repair proteins, shifts in immune function, or accumulated cellular damage—creates conditions where the protein is more likely to misfold.

However, age alone does not cause the disease. Most people who live into their 80s and 90s do not develop Lewy body dementia, which means other factors must determine who is vulnerable. Researchers are investigating whether differences in how individual brains handle protein cleanup, variations in genes that regulate alpha-synuclein, or exposure to environmental toxins over a lifetime influence risk.

Genetic and Family History Factors

Genetics play a role in Lewy body dementia, though the inheritance pattern is complex and most cases are not directly inherited. Researchers have identified mutations in genes like SNCA (which codes for alpha-synuclein itself), GBA, and LRRK2 that increase risk. People with a parent or sibling who had Lewy body dementia face higher risk than the general population, but having a family history does not mean someone will definitely develop the disease.

The same genes linked to Lewy body dementia also appear in Parkinson's disease and other neurodegenerative conditions, suggesting shared biological pathways. This genetic overlap may explain why some people develop Lewy body dementia while others with similar genetic risk develop Parkinson's or a mixed pathology—the same underlying vulnerability can manifest as different diseases depending on which brain regions are affected first and how severely.

Environmental and Lifestyle Exposures

Researchers have investigated whether environmental toxins, head injuries, or lifestyle factors trigger Lewy body dementia, but evidence remains limited and inconsistent. Some studies suggest that repeated head trauma (from falls, accidents, or contact sports) may increase risk, though a single head injury is not known to cause the disease. Occupational exposure to pesticides or heavy metals has been examined in some research, but no clear causal link has been established.

Lifestyle factors like physical activity, cognitive engagement, diet, and cardiovascular health may influence risk, but the evidence is weaker than for Alzheimer's disease. Some research hints that maintaining good heart health and staying mentally active might reduce risk, but these findings come from observational studies that cannot prove causation. The bottom line is that no specific environmental exposure has been proven to cause Lewy body dementia in the way that smoking causes lung cancer.

How Lewy Bodies Spread Through the Brain

The pattern of where Lewy bodies accumulate determines which symptoms appear first and how the disease progresses. In some people, Lewy bodies concentrate heavily in the brainstem and spread upward—this pattern often produces movement problems (like those seen in Parkinson's disease) alongside cognitive decline. In others, Lewy bodies are more widespread throughout the cortex from the start, causing memory loss and hallucinations as early symptoms.

Recent research suggests that alpha-synuclein may spread from cell to cell in a chain reaction, similar to how prion diseases propagate. This "prion-like" behavior could explain why the protein accumulation progresses over time rather than remaining static. However, the exact mechanisms that allow the protein to jump between cells and why it spreads in some brains but not others remain active areas of investigation.

Overlap With Alzheimer's and Parkinson's Pathology

Many brains with Lewy bodies also contain Alzheimer's pathology—amyloid plaques and tau tangles—or Parkinson's-related changes. This overlap complicates both diagnosis and understanding of cause. A person might have alpha-synuclein accumulation plus amyloid plaques, and researchers are still working to understand whether one pathology triggers the other, whether they develop independently, or whether certain genetic backgrounds make someone vulnerable to multiple types of protein misfolding.

This mixed pathology is one reason why Lewy body dementia can look different from person to person. Someone with Lewy bodies alone may have a different symptom pattern and disease course than someone with Lewy bodies plus Alzheimer's changes. Autopsy studies—the only way to definitively confirm Lewy body pathology—have shown that pure Lewy body dementia is actually less common than mixed presentations, which has shifted how researchers think about the disease's underlying causes.

What Researchers Still Do Not Know

Despite decades of study, fundamental questions remain unanswered. Why does alpha-synuclein misfold in the first place? What determines whether someone with the genetic risk will develop symptoms? Why do some people accumulate Lewy bodies for years without cognitive decline, while others decline rapidly? These gaps in understanding mean that no preventive treatment yet exists, and researchers cannot predict who will develop the disease.

Current research is focused on better understanding the early stages of protein accumulation, identifying biomarkers (measurable signs in blood or cerebrospinal fluid) that could detect the disease before symptoms appear, and testing whether clearing alpha-synuclein or preventing its misfolding could slow or stop progression. Several drugs targeting alpha-synuclein are in clinical trials, but it remains unclear whether removing the protein after damage has occurred can reverse cognitive decline.

Frequently Asked Questions

Can you catch Lewy body dementia from someone else?

No. Lewy body dementia is not contagious. It develops from protein misfolding within an individual's own brain cells, not from an infection or exposure to another person's disease. You cannot inherit it directly from a parent the way you inherit a single-gene disorder, though having a family member with the disease does increase your statistical risk.

Does head injury definitely cause Lewy body dementia?

A single head injury is not known to cause Lewy body dementia. Some research suggests repeated head trauma may increase risk, but the evidence is not conclusive. Many people experience head injuries without ever developing the disease, and many people with Lewy body dementia have no history of head injury.

Is Lewy body dementia the same as Parkinson's disease?

No, they are distinct conditions, though they share the same underlying protein (alpha-synuclein). Parkinson's primarily affects movement and develops when Lewy bodies concentrate in the brainstem. Lewy body dementia causes cognitive decline as a primary symptom. Some people develop both conditions, and the distinction between them can be blurry in individual cases.

Can diet or supplements prevent Lewy body dementia?

No supplement or diet has been proven to prevent Lewy body dementia. While general cardiovascular health and cognitive engagement may reduce risk for dementia overall, no specific dietary intervention targets alpha-synuclein accumulation. Claims about prevention through supplements are not supported by evidence.

Why is Lewy body dementia harder to diagnose than Alzheimer's?

Lewy bodies can only be confirmed by examining brain tissue after death. During life, doctors diagnose Lewy body dementia based on symptom patterns and sometimes imaging or spinal fluid tests, but these are less definitive than for Alzheimer's. The disease also mimics Parkinson's and Alzheimer's, and mixed pathology is common, making clinical diagnosis uncertain.